Pharmaceutical Medicaments (Retail Pack)

HS 300490 covers a broad residual category of retail-packaged medicaments not elsewhere classified, making it one of the highest-value and highest-volume pharmaceutical trade codes globally. India and China dominate as low-cost generic manufacturers and API suppliers, while Germany, Switzerland, and the US lead in branded and specialty formulations. Trade flows are heavily regulated, requiring import licenses, GMP certifications, and country-of-origin scrutiny due to counterfeiting risks and stringent pharmacovigilance requirements in destination markets.

Recent trade flows

• CH → US: $9504.6M (17.0% share)
• IN → US: $9080.3M (16.2% share)
• DE → US: $4564.2M (8.2% share)
• IT → US: $4347.3M (7.8% share)
• CN → US: $4127.5M (7.4% share)
• US → DE: $3218.6M (15.4% share)

What Logitality tells you for HS 300490

• Import duty rates by origin country — MFN, FTA, anti-dumping, safeguard duties
• Supplier depth — which origins have the most active supply base into your market
• FX movement impact — whether your currency is working for or against you
• AI-generated sourcing decision guide — which origin wins under which condition
• Feedstock and energy cost signals — early warning on supplier price changes
• Compliance flags — hazmat, dual-use, country of origin rules where applicable